814.17
price down icon2.47%   -20.58
after-market アフターアワーズ: 814.17
loading

Argen X Se Adr (ARGX) 最新ニュース

pulisher
Oct 16, 2025

TD Cowen Remains a Buy on Argenx Se (ARGX) - The Globe and Mail

Oct 16, 2025
pulisher
Oct 15, 2025

argenx stock price target maintained at $800 by TD Cowen on strong Vyvgart uptake - Investing.com

Oct 15, 2025
pulisher
Oct 15, 2025

Argenx Se (ARGX) Gets a Buy from Evercore ISI - The Globe and Mail

Oct 15, 2025
pulisher
Oct 13, 2025

How Do Investors Really Feel About argenx SE? - Sahm

Oct 13, 2025
pulisher
Oct 10, 2025

RBC Capital Remains a Buy on Argenx Se (ARGX) - The Globe and Mail

Oct 10, 2025
pulisher
Oct 08, 2025

Argenx NV stock hits all-time high at 803.95 USD By Investing.com - Investing.com South Africa

Oct 08, 2025
pulisher
Oct 08, 2025

Argenx NV stock hits all-time high at 803.95 USD - Investing.com

Oct 08, 2025
pulisher
Oct 04, 2025

Argenx SE Calls Extraordinary Shareholder Meeting for November 2025 - The Globe and Mail

Oct 04, 2025
pulisher
Oct 03, 2025

Goldman Sachs Sticks to Its Buy Rating for Argenx Se (ARGX) - The Globe and Mail

Oct 03, 2025
pulisher
Oct 02, 2025

Argenx stock hits all-time high at 781.12 USD By Investing.com - Investing.com Australia

Oct 02, 2025
pulisher
Oct 01, 2025

Argenx stock hits all-time high at 781.12 USD - Investing.com

Oct 01, 2025
pulisher
Oct 01, 2025

Argenx Se (ARGX) Gets a Buy from Morgan Stanley - The Globe and Mail

Oct 01, 2025
pulisher
Sep 30, 2025

Argenx Se (ARGX) Receives a Buy from RBC Capital - The Globe and Mail

Sep 30, 2025
pulisher
Sep 29, 2025

Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today - Sahm

Sep 29, 2025
pulisher
Sep 26, 2025

Price Over Earnings Overview: argenx - Sahm

Sep 26, 2025
pulisher
Sep 20, 2025

Leerink Partners Keeps Their Buy Rating on Viridian Therapeutics (VRDN) - The Globe and Mail

Sep 20, 2025
pulisher
Sep 18, 2025

Argenx Se (ARGX) Receives a Rating Update from a Top Analyst - The Globe and Mail

Sep 18, 2025
pulisher
Sep 18, 2025

Oppenheimer reaffirms Outperform rating on argenx stock after positive data - Investing.com

Sep 18, 2025
pulisher
Sep 17, 2025

Truist Securities reiterates Buy rating on argenx stock with $918 target - Investing.com

Sep 17, 2025
pulisher
Sep 16, 2025

$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today - Sahm

Sep 16, 2025
pulisher
Sep 16, 2025

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), KalVista Pharmaceuticals (KALV) and Argenx Se (ARGX) - The Globe and Mail

Sep 16, 2025
pulisher
Sep 15, 2025

Truist Securities assumes coverage on argenx stock with Buy rating - Investing.com

Sep 15, 2025
pulisher
Sep 12, 2025

Deutsche Bank downgrades Argenx to “hold” after 40% rally, €655 PT intact - Investing.com

Sep 12, 2025
pulisher
Sep 08, 2025

14 Newly Overvalued Stocks for the Week - Morningstar

Sep 08, 2025
pulisher
Sep 08, 2025

BofA Securities reaffirms Buy rating on argenx stock with $887 target - Investing.com

Sep 08, 2025
pulisher
Sep 03, 2025

Argenx stock hits all-time high at 716.89 USD - Investing.com

Sep 03, 2025
pulisher
Aug 27, 2025

Stocks Showing Improving Market Leadership: argenx ADR Earns 84 RS Rating - MSN

Aug 27, 2025
pulisher
Aug 26, 2025

Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded - Investor's Business Daily

Aug 26, 2025
pulisher
Aug 26, 2025

JPMorgan reiterates Overweight rating on argenx stock after positive trial - Investing.com

Aug 26, 2025
pulisher
Aug 25, 2025

Argenx Tops Buy Point On Bullish Study, 850 Price Target - Investor's Business Daily

Aug 25, 2025
pulisher
Aug 25, 2025

argenx stock rating reiterated by Oppenheimer after positive Phase 3 results - Investing.com

Aug 25, 2025
pulisher
Aug 25, 2025

Argenx: study met primary endpoint - AInvest

Aug 25, 2025
pulisher
Aug 25, 2025

argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG - GlobeNewswire Inc.

Aug 25, 2025
pulisher
Aug 21, 2025

Argenx Shares Rise 0.42% with $190M Volume Ranking 464th Amid Biotech Sector Surge - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

European ADRs Under Pressure: Sector Divergence and Strategic Entry Points - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

Earnings call transcript: Argenx Q2 2025 reports robust earnings beat - Investing.com

Aug 21, 2025
pulisher
Aug 19, 2025

Argenx's Growth Fuels Strong Demand for Vyvgart; Pipeline Continues to Develop - Morningstar

Aug 19, 2025
pulisher
Aug 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - GlobeNewswire Inc.

Aug 17, 2025
pulisher
Aug 15, 2025

This Stock Ran 31% In A Month. Will Upcoming News Revitalize It? - Investor's Business Daily

Aug 15, 2025
pulisher
Aug 12, 2025

argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis - Sahm

Aug 12, 2025
pulisher
Aug 08, 2025

argenx ADR Earns Relative Strength Rating Upgrade; Hits Key Benchmark - inkl

Aug 08, 2025
pulisher
Jul 31, 2025

Argenx NV ADR stock reaches all-time high at 689.13 USD By Investing.com - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 31, 2025

Argenx NV ADR stock reaches all-time high at 689.13 USD - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

argenx ADR earnings beat by $3.26, revenue topped estimates - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 31, 2025

BofA Securities raises argenx stock price target to $880 on strong Vyvgart sales - Investing.com

Jul 31, 2025
pulisher
Jul 21, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jul 21, 2025
pulisher
Jul 15, 2025

BofA Securities raises argenx stock price target to $829 on Vyvgart growth - Investing.com

Jul 15, 2025
pulisher
Jul 03, 2025

Morgan Stanley assumes coverage on argenx stock with Overweight rating - Investing.com

Jul 03, 2025
pulisher
Jul 01, 2025

Argenx stock advances as H.C. Wainwright reiterates Buy rating - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

argenx stock dips as FDA evaluates Vyvgart Hytrulo safety signal - Investing.com

Jun 30, 2025
pulisher
Jun 11, 2025

Argenx stock price target reiterated at $761 on positive trial data - Investing.com

Jun 11, 2025
pulisher
May 22, 2025

argenx SE’s SWOT analysis: biotech stock’s growth potential and challenges - Investing.com

May 22, 2025
pulisher
May 20, 2025

argenx ADR Shows Market Leadership With Jump To 84 RS Rating - Investor's Business Daily

May 20, 2025
pulisher
May 14, 2025

10 Stocks Analysts Are Upgrading Today - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

JMP cuts argenx stock target to $699, keeps outperform rating - Investing.com

May 14, 2025
pulisher
May 13, 2025

Baird raises argenx stock rating to Outperform, holds $680 target - Investing.com

May 13, 2025
pulisher
May 09, 2025

Argenx Earnings: Vyvgart Delivers Strong Sales Growth; Prefilled Syringe Expands Patient Access - Morningstar

May 09, 2025
$584.74
price up icon 0.93%
$464.90
price down icon 1.92%
biotechnology ONC
$313.54
price down icon 0.70%
$160.40
price down icon 2.97%
$106.23
price down icon 0.62%
大文字化:     |  ボリューム (24 時間):